Antibodies in Autoimmune, Chronic, and Infectious Diseases: Pathogenic Mechanisms, Biomarkers, and Vaccine Development
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines, Clinical Advancement, and Associated Immunology".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 724
Special Issue Editors
Interests: autoimmune diseases; antibody biomarkers; immunogenetics; inflammation; cytokines; B cell immunity; vaccines; chronic inflammatory diseases
Interests: cancer immunology; tumor microenvironment; antibody-based therapies; cytokines and inflammation; cellular immunotherapy; immunopathology; monoclonal and bispecific antibodies
Interests: autoimmune diseases; immunogenetics; inflammatory markers; antibody responses; cytokine networks; chronic inflammatory conditions; clinical immunology; diagnostic biomarkers; nutrition
Special Issue Information
Dear Colleagues,
Antibodies are central players in the immune system, acting as both sentinels and effectors in a wide range of physiological and pathological processes. In autoimmune diseases, antibodies often lose their specificity for foreign antigens and instead target self-components, contributing to chronic inflammation and tissue damage. In chronic conditions, antibodies may serve as biomarkers or modulators of disease progression, while in infectious diseases they are key components of both natural and vaccine-induced immunity.
The growing understanding of antibody diversity, functionality, and regulation has opened new avenues for diagnostic, prognostic, and therapeutic innovations. Moreover, the development of monoclonal antibodies, bispecific constructs, and antibody-based vaccines offers promising strategies for managing diseases that were previously difficult to treat.
This Special Issue aims to gather original research articles and comprehensive reviews that explore the roles of antibodies in autoimmune, chronic, and infectious diseases. We especially welcome contributions focused on antibody mechanisms, engineering, clinical applications, immune evasion strategies by pathogens, and novel approaches to antibody-based vaccine development.
We look forward to your valuable contributions.
Dr. Jorge Hernández-Bello
Dr. Mariel García Chagollán
Dr. Francisco Javier Turrubiates Hernández
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoantibodies
- monoclonal antibodies
- chronic diseases
- infectious diseases
- autoimmune diseases
- antibody-based vaccines
- immunotherapy
- antibody biomarkers
- b cell response
- translational immunology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
